Literature DB >> 2138472

Resistance to cisplatin: how to deal with the problem?

J L Canon1, Y Humblet, M Symann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2138472     DOI： 10.1016/0277-5379(90)90247-q

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  N-myc amplification and its relationship to experimental therapy.

Authors:  A Livingstone; R J Mairs
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

2.  Chemotherapy for non-small cell lung cancer.

Authors:  D P Carbone; J D Minna
Journal:  BMJ       Date:  1995-10-07

3.  High-dose 5-fluorouracil and leucovorin as second-line chemotherapy in patients with platinum-resistant epithelial ovarian cancer.

Authors:  J T Kamphuis; M C Huider; G J Ras; C A Verhagen; I Kateman; J H Vreeswijk; J T Burghouts
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.

Authors:  K J Mellish; L R Kelland; K R Harrap
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.